跳至主要内容
临床试验/NL-OMON55983
NL-OMON55983招募中不适用

A portable dyspnea RELIEF device for episodic breathlessness in COPD (PEP-buddy): effect on dyspnea severity and mechanism of action - RELIEF-study

niversitair Medisch Centrum Groningen0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >=40 years 2. Read, understood and signed Informed Consent 3. COPD Gold
  • class II-IV/ B or E (FEV1<60% of predicted, CAT >=10 points) 4. Optimized
  • standard therapy according to the study physician 5. Episodic breathlessness
  • requiring intervention (i.e. taking rest during physical activities, as needed
  • inhalation medication, breathing techniques, as needed opioids) at least three
  • days per week

排除标准

  • 1. Other severe disease causing episodic breathlessness
  • 2. Life expectancy <= 3 months
  • 3. Exacerbation of COPD 4 weeks prior to inclusion
  • 4. Change in COPD management targeted at breathlessness 8 weeks prior to
  • 5. Inability to use the PEP buddy device
  • 6. Currently participating in another interventional clinical study
  • 7. Any other conditions, which, in the opinion of the investigator would make
  • the patient unsuitable for inclusion, or could interfere with the patient
  • participating in or completing the study.

研究者

相似试验